Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» The Wisdom -- And Risk -- Of Pfizer's New Cholesterol Drug Development Plan
The Wisdom -- And Risk -- Of Pfizer's New Cholesterol Drug Development Plan
The Wisdom -- And Risk -- Of Pfizer's New Cholesterol Drug Development Plan
Submitted by
admin
on November 1, 2013 - 8:28am
Source:
Forbes
News Tags:
Pfizer
PCSK9 inhibitors
RN-316
Sanofi
Regeneron
REGN727
AMG145
Amgen
Headline:
The Wisdom -- And Risk -- Of Pfizer's New Cholesterol Drug Development Plan
Do Not Allow Advertisers to Use My Personal information
